Molar Pregnancy & Gestational Trophoblastic Disease
Admission & discharge
Admission/discharge guidance checked 2026-10-18 against the linked sources. This is a clinical checklist for an individual decision, not an automatic discharge order.
When admission or continued hospital care is needed
- Admit haemorrhage/instability, significant anaemia, severe pregnancy complications or a need for urgent evacuation; arrange experienced anaesthetic/transfusion support.
When clinic, day care or home care may be suitable
- After safe evacuation and recovery, most follow-up is through a specialist hCG surveillance service rather than continued hospital stay.
Before going home
- Bleeding and physiological recovery are satisfactory; histology is sent and the patient is registered/referred to the trophoblastic follow-up service.
- The patient understands that normal symptoms or one normal hCG do not by themselves complete surveillance.
Discharge medicines and treatment changes
- Document indicated RhD prophylaxis, anaemia treatment and effective contraception. Chemotherapy is a specialist-centre prescription, not a generic discharge course.
Tests, pending results and their reviewer
- FIGO 2025: hCG every 1–2 weeks until normal; partial mole confirms normal again at 1 month; complete mole needs monthly hCG for 6 months after normalisation. Plateau/rise requires prompt specialist review.
Home care and counselling
- Give the histology-specific follow-up schedule, the results contact and advice to avoid pregnancy until the surveillance service clears it.
Follow-up: when and what to review
| When | Action / responsible service |
|---|---|
Before leaving | Name the hCG service, book the first sample and establish who communicates histology. |
Through the complete surveillance period | Review missing/abnormal hCG promptly; plan an early scan in a future pregnancy. |
Return urgently
- Heavy bleeding, fainting, worsening pain, breathlessness or severe headache needs urgent assessment; an abnormal hCG callback must not be ignored.
Open the complete discharge checklist →
Treatment
① Immediate stabilization — first minutes
- Correct thyroid crisis/anaemia before anaesthesia if severe
- Crossmatch; suction evacuation readiness
③ First-line treatment & drug regimens
Suction evacuation, ideally with ultrasound guidance, preserves fertility. Arrange blood/anaesthetic support and histology; give indicated Rh immunoglobulin. Avoid routine repeat curettage. Hysterectomy is an option after completed childbearing but does not remove the need for hCG surveillance.
Definitive treatment
- EVACUATION IS TREATMENT for molar pregnancy itself
- GTN diagnosed by hCG criteria (rise/plateau per FIGO 2000 scoring) → oncology chemotherapy referral: low-risk single-agent (methotrexate/actinomycin-D); high-risk multiagent (EMA-CO) at accredited centre
Monitoring
| Finding | Action |
|---|---|
After evacuation | hCG every 1–2 weeks until normal; a plateau/rise needs prompt referral. |
Partial mole | Confirm normal hCG again after 1 month. |
Complete mole | Monthly hCG for 6 months after normalisation. |
FIGO postmolar GTN triggers | Plateau across four values over ≥3 weeks; rising values across three weekly measurements over ≥2 weeks; or histological choriocarcinoma. |
Contraception | Offer effective contraception during surveillance; hormonal methods are acceptable. Device suitability needs separate assessment. |
Treatment failure
- Second uterine evacuation considered ONLY for heavy bleeding with retained tissue + plateauing low hCG (max once; raises perforation risk)
Escalation
- ALL GTN → specialised trophoblastic centre (chemotherapy outcomes >90% even high-risk)
- Heavy haemoptysis/metastatic symptoms → urgent oncology
⑮ Complications & their management
Invasive mole/GTN
Chemotherapy pathways above; hysterectomy adjunct selected cases
Haemorrhage at evacuation
Uterotonics; balloon; embolisation standby
Hyperthyroidism
Beta-blocker cover peri-operatively until hCG falls
Post-treatment care
Complete the histology-specific surveillance before conception; give an early-scan plan for a subsequent pregnancy and clear contact arrangements for bleeding or abnormal results.
Diagnosis & assessment
Definition: Abnormal proliferative trophoblast: complete hydatidiform mole (diploid androgenetic), partial mole (diandric triploid), invasive mole/choriocarcinoma/placental-site tumours (GTN spectrum).
Presentation
- First-trimester bleeding ± hyperemesis
- Uterus larger than dates
- Hyperthyroidism (hCG-TSH cross-reactivity)
- Early pre-eclampsia <20 wks (classic, now less common with earlier scans)
- US snowstorm (complete) vs focal cystic changes with fetal parts (partial)
Initial assessment
- TVS + baseline βhCG (often >100,000 IU/L complete mole)
- CBC, coags, TFTs, creatinine, LFTs
- Chest X-ray only if symptoms/score suggests metastasis workup
- Type&screen; anaesthesia review for evacuation
Investigations
| Test | Looking for |
|---|---|
TVS | Diagnostic features; exclude coexisting normal twin (rare) |
Serum βhCG baseline + registry | Surveillance platform entry (India: regional cancer-centre registries where available) |
Histopathology + p57 immunostain (complete = p57 negative) | Definitive typing (partial vs complete matters for follow-up risk) |
Sources (6)
· checked 2026-10-18 · verified-live
Open source ↗
Primary paper sections 4–5: suction evacuation with ultrasound guidance and haemorrhage support, no routine second curettage, histology and referral, hCG every one/two weeks then partial-mole confirmatory test at one month versus complete-mole monthly six months; updated FIGO plateau/rise/histologic…
· checked 2026-10-18 · verified-live
Open source ↗
Full primary patient recovery page read: pain control, wounds, activity/VTE, urinary/bowel and infection warning signs, adult support and no driving/important decisions during the first 24 hours after general anaesthesia. Used as general recovery/handover principles, not operation-specific discharge…
· checked 2026-10-18 · verified-live
Open source ↗
Maternal/newborn transfer assessment, first void and effective feeding, handover, support/safeguarding, first midwife visit within 36 hours after transfer, postnatal danger symptoms. Full recommendations page read.
· checked 2026-10-18 · verified-live
Open source ↗
Normal-delivery discharge not less than 48 hours: full primary SOP PDF normal-delivery/discharge passages read. Corroborated by NHM CEmONC 2024 Part 1, chapter 8. This does not define a universal post-caesarean or complicated-case stay.
· checked 2026-10-18 · verified-live
Open source ↗
Official WHO summary read: at least 24-hour facility care after birth; additional contacts at 48–72 hours, 7–14 days and week 6; individual assessment/support. Summary facts only, not a claim that the full 242-page PDF was reviewed.
· checked 2026-10-18 · verified-live
Open source ↗
Full primary recommendations read, focusing on critical-care-to-ward transfer: structured written handover, shared plan, monitoring, rehabilitation and receiving-team capability. Step-down is distinct from home discharge; no universal organ-support discharge cutoff is asserted.